Markets:

Overview

News

Currencies

International

Treasuries

OptimizeRx Corporation - Common Stock (NQ:OPRX)

4.950 -0.140 (-2.75%)

Streaming Delayed Price Updated: 11:55 AM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 4 5 Next >

OptimizeRx (OPRX) Q1 2026 Earnings Transcript ↗

May 14, 2026

OptimizeRx (OPRX) Q1 2026 Earnings Transcript

Via The Motley Fool

OptimizeRx Q1 Earnings Call Highlights ↗

May 12, 2026

OptimizeRx (NASDAQ:OPRX) reported first-quarter fiscal 2026 results that topped consensus expectations, while management lowered its full-year revenue outlook, citing continued caution among life...

Via MarketBeat

Topics Earnings

OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidance ↗

May 12, 2026

Via Chartmill

Discover the top movers in Wednesday's pre-market session. ↗

March 18, 2026

Via Chartmill

OptimizeRx Corp (NASDAQ:OPRX) Beats Q4 Earnings Estimates but Offers Cautious 2026 Outlook ↗

March 05, 2026

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript ↗

March 05, 2026

OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Whetstone Capital Exits GitLab as Enterprises Rethink AI-Driven Software Development Tools ↗

February 26, 2026

Whetstone Capital Advisors has sold its stake in GitLab, a unified DevOps platform competing in the fast-changing market for AI-assisted coding and secure software delivery. As companies look at...

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

Whetstone Dumps 79,000 monday.com Shares Worth $15.3 Million ↗

February 21, 2026

This cloud-based software provider serves organizations worldwide with modular tools for work management and collaboration.

Via The Motley Fool

Topics Artificial Intelligence

Why One Fund Still Has a $14 Million Bet on This Resale Stock Up 130% This Past Year ↗

December 08, 2025

One luxury resale stock is quietly delivering its strongest growth in years — despite insiders taking some profits.

Via The Motley Fool

Topics Regulatory Compliance

BrightView Shares Down 30%: What a Full Fund Exit Signals for Investors ↗

December 08, 2025

One fund just walked away from BrightView — here’s what the numbers suggest long-term investors should really pay attention to.

Via The Motley Fool

Topics Regulatory Compliance

Why One Fund Added 415,000 Shares of a Software Stock Down 26% This Past Year ↗

December 08, 2025

One fast-growing software company just won a major vote of confidence — here’s what’s behind it.

Via The Motley Fool

This Fund Just Bought $6 Million in Plug Power Stock — Is a Turnaround in Sight? ↗

December 08, 2025

One formerly high-flying alternative energy stock just got a surprising vote of confidence — here’s what the latest numbers reveal.

Via The Motley Fool

Topics Economy Regulatory Compliance

Whetstone Sells All Freshworks Shares ↗

November 23, 2025

The investment firm sold all of its shares in the AI firm.

Via The Motley Fool

Topics Artificial Intelligence Initial Public Offering Regulatory Compliance

OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript ↗

November 10, 2025

OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

OptimizeRx Corp (NASDAQ:OPRX) Shows High-Growth Momentum with Strong Technical Breakout ↗

November 07, 2025

OptimizeRx (OPRX) stock shows a powerful breakout setup, combining a strong technical uptrend with explosive earnings and sales growth momentum.

Via Chartmill

OptimizeRx Corp (NASDAQ:OPRX) Delivers Strong Q3 Beat and Raises Guidance ↗

November 06, 2025

OptimizeRx Q3 earnings crush estimates with strong revenue and profit growth. The healthcare tech firm also raises its full-year 2025 guidance.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 06, 2025

Via Benzinga

OPTIMIZERX CORP (NASDAQ:OPRX) Shows Strong Momentum with Minervini Trend Template and High Growth Fundamentals ↗

October 13, 2025

Discover how OptimizeRx (OPRX) exemplifies the Minervini Trend Template, combining strong technical momentum with explosive fundamental growth for a powerful stock setup.

Via Chartmill

UnitedHealth Group Under Siege: DOJ Probes and Cyberattack Aftermath Shake Healthcare Giant

September 19, 2025

UnitedHealth Group (NYSE: UNH), a dominant force in the U.S. healthcare landscape, is currently embroiled in an unprecedented storm of regulatory and legal scrutiny. Federal Justice Department probes...

Via MarketMinute

Topics Economy Lawsuit

OptimizeRx Corp (NASDAQ:OPRX) Combines Technical Strength with High-Growth Momentum ↗

September 06, 2025

OptimizeRx (OPRX) combines strong technical uptrend with explosive earnings growth, making it a top growth and momentum stock pick.

Via Chartmill

Top stock movements in today's session. ↗

August 08, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 08, 2025

Via Benzinga

These stocks are moving in today's session ↗

August 08, 2025

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Which stocks are moving before the opening bell on Friday? ↗

August 08, 2025

Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 08, 2025

Via Benzinga

Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

August 08, 2025

Via Benzinga

OptimizeRx Stock Rallies 22% After-Hours Thanks To Q2 Earnings Push ↗

August 07, 2025

OptimizeRx's stock jumped 22.66% after hours following strong Q2 earnings that beat expectations and lifted the share price from $12.84 to $15.75.

Via Benzinga

OptimizeRx Corp (NASDAQ:OPRX) Surges 15% After Blowout Q2 Earnings and Raised 2025 Guidance ↗

August 07, 2025

OptimizeRx Q2 2025 earnings crush estimates with $29.2M revenue (+55% YoY) and $0.24 EPS, sparking a 15% stock surge. Raised guidance signals strong growth ahead.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 07, 2025

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.